Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIITerminatedF-0463-2024

Supplement recall · November 29, 2023

ACTIRON Dietary Supplement recall

Why: FDA sample analysis of ACTIRON Dietary Supplement, 100 Tablets, Lot 13309, found the product did not meet folic acid specification compared to the label claim.

Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).

The recall

Product

ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104.

Lots / codes

Lot 13309, Exp: 01/26

Quantity
607 bottles of 100 tablets each
Company
ActiPharma, Inc., Guaynabo, PR
Distribution
Domestic distribution, in Puerto Rico.
Initiated
September 28, 2023 · Voluntary: Firm initiated
Classified
November 17, 2023
Reported
November 29, 2023
Ended
January 16, 2024
How notified
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.